Michael P. Rubin serves as Executive at DICE Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Michael P. Rubin has executed 3 insider transactions totaling $4.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Sep 17, 2021 involved purchasing 235,000 shares valued at $4.0M.
Michael P. Rubin currently holds 3,292,871 shares of DICE Therapeutics, Inc. (DICE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael P. Rubin has been a net buyer of DICE stock. They have purchased $4.0M and sold $0 worth of shares.
Michael P. Rubin's most recent insider trade was on Sep 17, 2021, when they purchased 235,000 shares at $17.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 17, 2021 | DICE | $0 | Conversion | 454,796 | $N/A | Discretionary |